Re: Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease.
Re: Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease. Int J Impot Res. 2020 03; 32(2):257-258.